Cloverfields Capital Group, LP Astrazeneca PLC Transaction History
Cloverfields Capital Group, LP
- $273 Million
- Q1 2024
A detailed history of Cloverfields Capital Group, LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Cloverfields Capital Group, LP holds 37,693 shares of AZN stock, worth $2.94 Million. This represents 0.94% of its overall portfolio holdings.
Number of Shares
37,693
Previous 37,268
1.14%
Holding current value
$2.94 Million
Previous $2.51 Million
1.75%
% of portfolio
0.94%
Previous 1.04%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,246Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.78 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.83 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.35 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.69 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.35 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...